Formulation and evaluation of co-prodrug of flurbiprofen and methocarbamol
The current work envisages synthesis of an ester prodrug of flurbiprofen whereby its carboxylic group was condensed with a skeletal muscle relaxant methocarbamol, with the aim of synergistic activity of two drugs, avoid flurbiprofen mediated gastro-intestinal damage and minimize the ulceration tende...
Main Authors: | Neela Bhatia, Kiran Katkar, Snehal Ashtekar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087615001312 |
Similar Items
-
Flurbiprofen–antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling
by: Ashraf Z, et al.
Published: (2016-07-01) -
Application of Box-Behnken experimental design and response surface methodology for selecting the optimum RP-HPLC conditions for the simultaneous determination of methocarbamol, indomethacin and betamethasone in their pharmaceutical dosage form
by: Ehab F. Elkady, et al.
Published: (2022-12-01) -
Comparison of atracurium and methocarbamol for preventing succinylcholine-induced muscle fasciculation: A randomized controlled trial
by: Gholamreza Shabanian, et al.
Published: (2017-01-01) -
A Case Report of Unusual Vasculitic Reaction after Methocarbamol Injection
by: Maryam Sahebari, et al.
Published: (2011-03-01) -
A Case Report of Unusual Vasculitic Reaction After Methocarbamol Injection
by: Maryam Sahebari, et al.
Published: (2011-03-01)